DHR raises EPS guide
Danaher's adjusted EPS beat and full-year guidance moved higher, while revenue came in slightly below consensus and core growth accelerated excluding respiratory.
Sources: https://www.sec.gov/Archives/edgar/data/313616/000031361626000201/dhr-20261021xex991.htm
Previous verdicts for DHR
- AI Search: Danaher drifts slightly higher amid routine filings and commentary — 2026-11-09
- AI Search: Danaher Edges Higher as FDA Clearance Fuels Bull Case — 2026-11-04
- AI Search: Analyst Price Target Increase Lifts Danaher as Market Slips — 2026-11-03
- DHR lifts with tech — 2026-10-29
- AI Search: Danaher Climbs Sharply on Buy Upgrade and NVIDIA Collaboration Headline — 2026-10-28
Ezbrisk weighs each event against the market reaction and publishes a verdict with an overreaction reading. How the methodology works